Experimental drug the 'best choice' for American journalist with Ebola
Posted on AllSides October 7th, 2014
From The Right
An American journalist who contracted Ebola while working in Liberia is now being treated with an experimental drug, the same drug the first Ebola patient diagnosed in the U.S. is receiving.
On Tuesday, Nebraska Medical Center announced Ashoka Mukpo, 33, is being treated with brincidofovir, made by biopharmaceutical company Chimerix.
